MEDIPOST Co., Ltd. (KOSDAQ:078160)

South Korea flag South Korea · Delayed Price · Currency is KRW
18,130
-100 (-0.55%)
Dec 10, 2025, 3:30 PM KST
108.15%
Market Cap712.53B
Revenue (ttm)73.59B
Net Income (ttm)-97.90B
Shares Out39.09M
EPS (ttm)-2,925.08
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume102,000
Average Volume113,757
Open18,200
Previous Close18,230
Day's Range17,620 - 18,400
52-Week Range7,490 - 20,500
Beta0.71
RSI54.78
Earnings DateNov 13, 2025

About MEDIPOST

MEDIPOST Co., Ltd. engages in the cord blood bank business in South Korea and internationally. The company operates through three divisions: Cord Blood Bank, Stem Cell Therapy, and Health Functional Food. It operates cord blood bank under the CELLTREE name. The company also offers CARTISTEM for the treatment of repetitive and/or traumatic cartilage degeneration, including degenerative osteoarthritis. In addition, it is developing stem cell products, such as PNEUMOSTEM for the preventative treatment of bronchopulmonary dysplasia. Further, the co... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 322
Stock Exchange KOSDAQ
Ticker Symbol 078160
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.